ATLANTA, GA, Nyra Medical, a medical device company, announced the closing of a $20 million Series A financing.
Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, announced the closing of a $20 million Series A financing. The round was co-led by Vensana Capital and a large, global medical device company, alongside additional investors Broadview Ventures, Epidarex Capital, and the Georgia Research Alliance Venture Fund.
Nyra is developing a transcatheter technology (CARLEN), which modifies the native mitral valve leaflets with a proprietary implant, to correct for deficiencies that otherwise lead to mitral regurgitation, while preserving the physiological valve geometry.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about